CLEVELAND, Ohio (October 20, 2026)—Hot flashes are the most frequent symptom of perimenopause and menopause, affecting 75% to 85% of women. In recent years, there has been a spike in the number of nonhormone options for managing hot flashes. A new study suggests that transdermal nitroglycerin may be an option. Results of the study will be presented at the 2026 Annual Meeting of The Menopause Society in San Diego October 20-24, 2026.

CLEVELAND, Ohio (October 20, 2026)­­ – Neurokinin receptor (NKR) antagonists are already widely used for treating menopausal hot flashes, representing a highly effective nonhormone treatment. A new study suggests they may also help breast cancer patients by limiting the spread of cancer cells and helping to prevent a recurring cancer diagnosis. Results of the study will be presented at the 2026 Annual Meeting of The Menopause Society in San Diego October 20-24, 2026.

CLEVELAND, Ohio (October 20, 2026)—Cognitive behavioral therapy (CBT) has proven effective in managing a number of menopause symptoms, including hot flashes, insomnia, depression, and sexual dysfunction. However, access remains limited. A new study suggests that virtual reality (VR) and artificial intelligence (AI) could be effective in delivering CBT interventions. Results of the study will be presented at the 2026 Annual Meeting of The Menopause Society in San Diego October 20-24, 2026.

The national reference gives innovators, investigators and ethics committees an internationally aligned benchmark for device study applications, strengthening Singapore’s position as a trusted location for medtech clinical research.

Researchers have discovered the genetic blueprints of 18 new bacterial species collected from prostate cancer patients.

The team recovered 249 near-complete bacterial genomes from 194 prostate cancer patients. Twenty-four of these did not match any species on record.

Most came from saliva samples in the mouth, including new types of Porphyromonas, which the team has previously linked to more aggressive prostate cancer,  and Treponema. Whether they contribute to prostate cancer is unknown, but this work provides new insights into microbes in cancer patients and could uncover links that improve our  understanding of how cancer develops.  

In a new study, Mass General Brigham researchers used a model to simulate the impact of the new HBV vaccination recommendations on HBV infections and susceptibility. Compared with universal vaccination at birth, they estimated that delaying HBV vaccination until infants are two months old would increase the number of chronic HBV infections by around 19%, whereas a shared decision-making strategy would increase infections by around 83%.

A modeling study suggests that replacing universal hepatitis B vaccination at birth with delayed vaccination or a shared decision-making approach, as recommended by the U.S. federal government this year, could lead to substantially more chronic hepatitis B infections among U.S. children.